Skip to content

Drug interactions

Rolapitant + Rosuvastatin

Severity: Moderate

Rolapitant and Rosuvastatin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rolapitant inhibits BCRP, a transporter involved in rosuvastatin absorption and elimination. Rosuvastatin exposure increases substantially, which raises the risk of myopathy and rhabdomyolysis.

What this interaction means in plain words

Rolapitant and Rosuvastatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Rolapitant belongs to Gastrointestinal Tract; Rosuvastatin belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Rolapitant inhibits intestinal and hepatic BCRP, increasing rosuvastatin systemic exposure.

What to do

Use the lowest effective rosuvastatin dose during rolapitant use. Counsel patients to report muscle pain or weakness and monitor CK if symptoms occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rolapitant and Rosuvastatin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rolapitant with Rosuvastatin?

MediHelp rates the interaction as moderate. Rolapitant and Rosuvastatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rolapitant inhibits BCRP, a transporter involved in rosuvastatin absorption and elimination. Rosuvastatin exposure increases substantially, which raises the risk of myopathy and rhabdomyolysis.

How serious is the interaction between Rolapitant and Rosuvastatin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use the lowest effective rosuvastatin dose during rolapitant use. Counsel patients to report muscle pain or weakness and monitor CK if symptoms occur.

What other medicines interact with Rolapitant?

MediHelp also lists interactions of Rolapitant with, for example, Pimozide, Thioridazine, Atomoxetine. The full list is on the Rolapitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in